Bioxyne Archives | Cannabiz

BLS triples profit, tips revenue to grow up to 55% in FY27

by Adam Sheldon August 31, 2026August 31, 2026

BLS Pharmaceuticals managing director Sam Watson said the firm has established “solid foundations” for further growth […]

BLS hits top end of guidance after strong final quarter of FY26

by Steve Jones July 27, 2026July 28, 2026

News in brief: Legalise Cannabis Victoria seeks $10,000; Bioxyne confirms BLS rebrand

by Adam Sheldon June 29, 2026July 2, 2026

Bioxyne to be renamed as BLS Pharmaceuticals to ‘reduce brand confusion’

by Adam Sheldon June 23, 2026June 25, 2026

Bioxyne signs $50 million German deal

by Adam Sheldon May 12, 2026May 12, 2026

Bioxyne lands first Costa Rica flower supply deal

by Adam Sheldon May 11, 2026May 11, 2026

Bioxyne ‘on track’ to hit guidance after sharp revenue growth in Q3

by Steve Jones April 21, 2026April 21, 2026

Bioxyne lands Aurora Cannabis manufacturing deal

by Adam Sheldon April 1, 2026April 1, 2026

Domestic market could ‘double’ on back of driving law reform: Bioxyne

by Adam Sheldon March 25, 2026March 25, 2026

Rec-style branding risks undermining the industry, warns Bioxyne CEO

by Adam Sheldon March 12, 2026March 12, 2026